drugset / Trial / NCT00502463

Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial

NCT00502463

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the trial is to determine the feasibility of an induction chemotherapy with radio-immunotherapy in patients with head and neck cancer stage III/IV

Timeline

Start
2007-10-03
Primary completion
2010-01-19
Completion
2014-01-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetuximab Monoclonal antibody 250 mg/m2
Subject Cisplatin Other / unclassified 75 mg/m2
Subject Docetaxel Small molecule 75 mg/m2
Subject fluorouracil Small molecule 750 mg/m2

Indications